Lv41
464 积分 2022-07-18 加入
Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension
7小时前
待确认
Pulmonary hypertension
2天前
已完结
Drugs targeting novel pathways in pulmonary arterial hypertension
3天前
已完结
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
2个月前
已完结
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
2个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
2个月前
已完结
Efficacy and safety of sunvozertinib monotherapy as first-line treatment in NSCLC patients with EGFR exon 20 insertion mutations: A phase 2, single-center trial
2个月前
已完结
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
2个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
2个月前
已完结
A Phase 2 Multi-Center, Placebo-Controlled, Randomized Study to Assess the Safety and Efficacy of Parenteral TK-90 for Preventing Radiation-Induced Mucositis in Patients with Squamous Cell Carcinoma of the Head and Neck
5个月前
已关闭
皖公网安备34019202002308
